|
6-iodo-[1,2,4]triazolo[1,5-a]pyridine
|
6-碘-[1,2,4]三唑并[1,5-A]吡啶
|
614750-84-4
|
|
Tosedostat
|
托舍多特
|
238750-77-1
|
|
BMS-794833
|
BMS-794833
|
1174046-72-0
|
|
AST487
|
AST 487
|
630124-46-8
|
|
LoMitapide Mesylate
|
甲磺酸洛美他派
|
202914-84-9
|
|
GNE7915
|
GNE7915
|
1351761-44-8
|
|
SCR-1438
|
4-(4-amino-2-fluorophenoxy)-3-chloro-N-(diphenylmethylene)-2-Pyridinamine
|
1174046-76-4
|
|
2'3'-cGAMP
|
2,3-CGAMP
|
1441190-66-4
|
|
PCO371
|
PCO371
|
1613373-33-3
|
|
2,5-Dichloro-4-iodopyridine
|
2,5-二氯-4-碘吡啶
|
796851-03-1
|
|
3-deazaneplanocin A
|
3-去氮腺嘌呤A
|
120964-45-6
|
|
RTA-408
|
NRF1-ACTIVATOR-1
|
1474034-05-3
|
|
SEP-0372814
|
3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline
|
1516896-09-5
|
|
BAY-1217389
|
CS-2361
|
1554458-53-5
|
|
AZD-1390
|
CS-2816
|
2089288-03-7
|
|
ARS 1620
|
CPD1588
|
1698055-85-4
|
|
L-685 458
|
CS-2367
|
292632-98-5
|
|
PST2238
|
ROSTAFUROXIN
|
156722-18-8
|
|
NG25
|
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺
|
1315355-93-1
|
|
INCB-024360
|
4-氨基-N-(3-氯-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒
|
914471-09-3
|
|
RGFP966
|
(2E)-N-(2-氨基-4-氟苯基)-3-[1-(3-苯基-2-丙烯-1-基)-1H-吡唑-4-基]-2-丙烯酰胺
|
1396841-57-8
|
|
SAR191801
|
化合物HPGDS-IN-1
|
1234708-04-3
|
|
ACY-738
|
N-羥基-2-[(1-苯基環(huán)丙基)氨基]-5-嘧啶甲酰胺
|
1375465-91-0
|
|
MI-503
|
MI-503
|
1857417-13-0
|
|
MK-8722
|
MK-8722
|
1394371-71-1
|
|
NSC-706744
|
LMP744; LMP-744; LMP 744; MJ-III-65; NSC-706744
|
308246-57-3
|
|
TAS4464
|
TAS4464
|
1848959-10-3
|
|
Amonafide
|
氨萘非特
|
69408-81-7
|
|
Mitonafide
|
米托萘胺
|
54824-17-8
|
|
VX809
|
魯瑪卡托
|
936727-05-8
|
|
MLN-2480
|
MLN2480
|
1096708-71-2
|
|
Lesinurad
|
雷西那德
|
878672-00-5
|
|
PND-1186
|
PND1186
|
1061353-68-1
|
|
DBPR211
|
1-(2,4-二氯苯基)-N-1-哌啶基-4-[[(1-吡咯烷基磺酰基)氨基]甲基]-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺
|
1429239-98-4
|
|
Ivosidenib
|
艾伏尼布
|
1448347-49-6
|
|
NU-9056
|
NU 9056
|
1450644-28-6
|
|
(S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-amine
|
CPD3615-A5
|
2045894-03-7
|
|
CFI-402257
|
CS-2627
|
1610759-22-2
|
|
CPFX4158
|
CPFX4158
|
1804962-84-2
|
|
Uridine 5'-Diphosphoglucose Disodium Salt
|
二磷酸尿苷葡萄糖二鈉鹽
|
28053-08-9
|
|
GDC-0941
|
GDC-0941
|
957054-30-7
|
|
Tavaborole
|
他伐硼羅
|
174671-46-6
|
|
GSK 1070916
|
GSK1070916
|
942918-07-2
|
|
BGB-324; R428
|
R428
|
1037624-75-1
|
|
RX-3117 int
|
RX-3117中間體
|
805245-41-4
|
|
TP808
|
TP808
|
852821-06-8
|
|
CPI-444
|
CPI-444
|
1202402-40-1
|
|
Ozanimod
|
奧扎莫德
|
1306760-87-1
|
|
EW-7197
|
EW-7197
|
1352608-82-2
|
|
IDO inhibitor 1
|
艾卡哚司他
|
1204669-58-8
|
|
EPZ031686
|
CS-2707
|
1808011-22-4
|
|
CXD101
|
CXD-101
|
934828-12-3
|
|
HM43239
|
化合物HM43239
|
2569527-64-4
|
|
LDE-225 (SONIDEGIB)
|
索尼吉布
|
956697-53-3
|
|
Refametinib
|
瑞法替尼
|
923032-37-5
|
|
Enasidenib (AG-221)
|
恩西地平
|
1446502-11-9
|
|
SAR348830
|
(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol
|
1462949-64-9
|
|
BGB3111
|
(±)-贊魯替尼
|
1633350-06-7
|
|
VH-032
|
VH-032
|
1448188-62-2
|
|
Venadaparib
|
Venadaparib
|
1681017-83-3
|
|
gSK-461364
|
GSK461364
|
929095-18-1
|
|
LoMitapide
|
洛美他派
|
182431-12-5
|
|
IDO inhibitor 1
|
4-[[2-[(氨基磺?；?氨基]乙基]氨基]-N'-(3-溴-4-氟苯基)-N-羥基-1,2,5-惡二唑-3-甲脒
|
1204669-37-3
|
|
BCI
|
BCI
|
1245792-51-1
|
|
CBP-307
|
[CBP-307]
|
|
|
(S)-PF-06873600
|
(S)-PF-06873600
|
2185859-59-8
|
|
M4205
|
化合物M4205
|
2590556-80-0
|
|
ZZW-115 hydrochloride
|
ZZW-115 hydrochloride
|
10122-45-9
|
|
PST2744
|
PST-2744
|
203737-93-3
|
|
GSK 561679A
|
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-惡二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺
|
885220-61-1
|
|
X-376
|
恩沙替尼
|
1365267-27-1
|
|
TBA-354
|
TBA-354
|
1257426-19-9
|
|
Mitapivat
|
PKR-IN-1
|
1260075-17-9
|
|
KPT9274
|
KPT-9274
|
1643913-93-2
|
|
CF102
|
2-CL-IB-MECA
|
163042-96-4
|
|
RX-518
|
RX-518
|
1660963-42-7
|
|
LOXO195
|
LOXO195
|
1350884-56-8
|
|
Inarigivirsoproxil
|
INARIGIVIR SOPROXIL
|
942123-43-5
|
|
Vafidemstat(ORY-2001)
|
VAFIDEMSTAT
|
1357362-02-7
|
|
IPN-60090
|
IPN-60090
|
1853164-83-6
|
|
JHU37160
|
化合物JHU 37160
|
2369979-68-8
|
|
3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-7-CARBOXYLIC ACID
|
3-氧代-3,4-二氫-2H-1,4-苯并惡嗪-7-羧酸
|
214848-62-1
|
|
AZD-8055
|
AZD8055
|
1009298-09-2
|
|
BAY-57-1293
|
普瑞利韋
|
348086-71-5
|
|
PXD-101
|
貝利司他
|
866323-14-0
|
|
EPZ-6438
|
EPZ-6438
|
1403254-99-8
|
|
GZD824
|
GZD824
|
1257628-77-5
|
|
GZD824
|
GZD824DIMESYLATE
|
1421783-64-3
|
|
ASP-2215 (GILTERITINIB)
|
吉列替尼
|
1254053-43-4
|
|
TP-2857
|
TP-2857
|
1575491-01-8
|
|
LOXO-195
|
LOXO-195
|
2097002-61-2
|
|
PF-06873600
|
PF-06873600
|
2185857-97-8
|
|
S-22611
|
PVM/MA共聚物
|
1644545-52-7
|
|
MLN4924
|
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氫-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羥基環(huán)戊基]甲基酯
|
905579-51-3
|
|
Mdivi-1
|
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氫-2-硫代-4(1H)-喹唑啉酮
|
338967-87-6
|
|
PST2286
|
PST2286
|
26629-41-4
|
|
AZD6738
|
AZD6738
|
1352226-88-0
|
|
AVITINIB
|
N-(3-((2-((3-氟-4-(4-甲基哌嗪-1-基)苯基)氨基)-7H-吡咯并[2,3-D]嘧啶-4-基)氧基)苯基)丙烯酰胺酸鹽
|
1557268-88-8
|
|
AZD-0364
|
CS-2696
|
2097416-76-5
|
|
A8301
|
3-(6-甲基-2-吡啶基)-N-苯基-4-(4-喹啉基)-1H-吡唑-1-硫代甲酰胺
|
909910-43-6
|